National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 1) (PB 10 of 2018) (Cth)

PB 10 of 2018

National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 1)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated       29   January 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2018 (No. 1).

(2)   This Determination may also be cited as PB 10 of 2018.

1. Commencement

This Determination commences on 1 February 2018.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Coal tar

Omit

Coal tar-prepared

[2]     Schedule 1, after item dealing with Cyclophosphamide

Omit

Cyproheptadine

[3]     Schedule 1, after item dealing with Glycomacropeptide and essential amino acids with vitamins and minerals

Insert

Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine

[4]     Schedule 1, after item dealing with Obinutuzumab

Insert

Ocrelizumab

[5]     Schedule 1, after item dealing with Ticagrelor

Omit

Ticarcillin with clavulanic acid

[6]     Schedule 2,

Insert as first item

Abacavir with Lamivudine